Projected Income Statement: TGS ASA

Forecast Balance Sheet: TGS ASA

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 -193 -182 -188 -112 489 456 504 485
Change - 5.7% -3.3% 40.43% 536.61% -6.73% 10.53% -3.77%
Announcement Date 2/11/21 2/10/22 2/9/23 2/15/24 2/20/25 - - -
1USD in Million
Estimates

Cash Flow Forecast: TGS ASA

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
CAPEX 1 376.3 169.1 224.6 428.1 399.7 116.5 105 110
Change - -55.08% 32.82% 90.64% -6.62% -70.86% -9.87% 4.76%
Free Cash Flow (FCF) 1 -21.62 148.6 70.43 156.7 229 250.5 168 184.8
Change - 787.3% -52.6% 122.44% 46.14% 9.4% -32.93% 9.97%
Announcement Date 2/11/21 2/10/22 2/9/23 2/15/24 2/20/25 - - -
1USD in Million
Estimates

Forecast Financial Ratios: TGS ASA

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027

Profitability

        
EBITDA Margin (%) 77.79% 63.45% 75.19% 48.33% 52.66% 58.36% 58.89% 58.91%
EBIT Margin (%) -65.29% -52.32% 18.24% 6.71% 14.83% 13.85% 12.75% 13.95%
EBT Margin (%) -64.55% -12.93% 17.8% 6.53% 11.19% 8.78% 9.22% 10.59%
Net margin (%) -45.65% -17.52% 12.09% 2.73% 7.15% 3.07% 6.35% 7.25%
FCF margin (%) -4.82% 48.1% 9.83% 19.73% 17.37% 16.54% 11.81% 12.69%
FCF / Net Income (%) 10.55% -274.6% 81.27% 723.81% 243.03% 538% 185.86% 174.95%

Profitability

        
ROA -4.95% -2.98% 4.92% 1.14% 3.14% - - -
ROE -14.66% -4.59% 7.35% - 5.62% 2.26% 5% 5.57%

Financial Health

        
Leverage (Debt/EBITDA) - - - - 0.7x 0.52x 0.6x 0.56x
Debt / Free cash flow - - - - 2.14x 1.82x 3x 2.62x

Capital Intensity

        
CAPEX / Current Assets (%) 83.86% 54.74% 31.33% 53.89% 30.33% 7.69% 7.38% 7.55%
CAPEX / EBITDA (%) 107.8% 86.27% 41.67% 111.51% 57.58% 13.18% 12.53% 12.82%
CAPEX / FCF (%) -1,740.89% 113.79% 318.81% 273.23% 174.59% 46.51% 62.5% 59.54%

Items per share

        
Cash flow per share 1 3.03 2.7 2.893 4.598 3.18 4.383 3.716 3.918
Change - -10.88% 7.12% 58.93% -30.82% 37.8% -15.22% 5.46%
Dividend per Share 1 0.5 0.56 0.56 0.56 0.56 0.608 0.599 0.602
Change - 12% 0% 0% 0% 8.57% -1.48% 0.5%
Book Value Per Share 1 10.66 9.58 9.983 9.713 10.58 10.21 10.04 9.985
Change - -10.13% 4.21% -2.71% 8.89% -3.43% -1.68% -0.56%
EPS 1 -1.75 -0.46 0.73 0.17 0.52 0.2366 0.4615 0.5381
Change - 73.71% 258.7% -76.71% 205.88% -54.5% 95.06% 16.59%
Nbr of stocks (in thousands) 117,228 116,107 124,469 130,862 196,213 196,459 196,459 196,459
Announcement Date 2/11/21 2/10/22 2/9/23 2/15/24 2/20/25 - - -
1USD
Estimates
2025 *2026 *
P/E ratio 41x 21x
PBR 0.95x 0.97x
EV / Sales 1.56x 1.7x
Yield 6.26% 6.17%
More valuation ratios * Estimated data

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
6
Last Close Price
9.710USD
Average target price
8.195USD
Spread / Average Target
-15.60%
Consensus

Quarterly revenue - Rate of surprise